Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Lumos Pharma, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
LUMO is no longer listed, so this page shows Q3 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 29
- −6 vs. Q2 2024
- Shares held
- 2.09M
- +51.3K (+2.5%) vs. Q2 2024
- Total value
- $8.08M
- +$3.36M (+71.0%) vs. Q2 2024
- New holders
- 3
- 2 more added
- Sold out
- 9
- 11 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUMO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 29 | $8.08M |
| Q2 2024 | 36 | $4.82M |
| Q1 2024 | 36 | $6.14M |
| Q4 2023 | 37 | $7.52M |
| Q3 2023 | 34 | $8.05M |
| Q2 2023 | 35 | $7.90M |
| Q1 2023 | 37 | $7.40M |
| Q4 2022 | 38 | $8.51M |
| Q3 2022 | 35 | $23.0M |
| Q2 2022 | 36 | $18.7M |
| Q1 2022 | 36 | $23.3M |
| Q4 2021 | 38 | $18.7M |
| Q3 2021 | 37 | $27.3M |
| Q2 2021 | 40 | $32.1M |
| Q1 2021 | 41 | $38.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Lumos Pharma, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 50 | $0 | 0.00% | −28−35.9% | Reduced |
| Jones Financial Companies LLLP | 4 | $16 | 0.00% | 00.0% | Unchanged |
| Live Oak Investment Partners | – | $43 | 0.00% | – | – |
| JPMorgan Chase & Co | 13 | $50 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 166 | $642 | 0.00% | −111−40.1% | Reduced |
| Advisor Group Holdings, Inc. | 290 | $1.12K | 0.00% | −20−6.5% | Reduced |
| West Financial Advisors, LLC | 784 | $3.04K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,225 | $4.74K | 0.00% | −2,357−65.8% | Reduced |
| Bank of America Corp | 1,800 | $6.97K | 0.00% | 00.0% | Unchanged |
| Paladin Advisory Group, LLC | 4,387 | $17.0K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 6,557 | $25.4K | 0.00% | +6,557 | New |
| ADAR1 Capital Management, LLC | 10,000 | $38.7K | 0.01% | +10,000 | New |
| Key Financial Inc | 10,927 | $42.3K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 11,130 | $43.1K | 0.00% | −7,815−41.3% | Reduced |
| State Street Corp | 11,237 | $43.5K | 0.00% | 00.0% | Unchanged |
| Wealth Advisors of Iowa, LLC | 11,699 | $45.3K | 0.02% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,858 | $45.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 19,643 | $76.0K | 0.00% | −8,000−28.9% | Reduced |
| Dimensional Fund Advisors LP | 25,278 | $97.8K | 0.00% | −4,309−14.6% | Reduced |
| Lion Point Capital, LP | 39,589 | $153.2K | 0.61% | −51,205−56.4% | Reduced |
| BlackRock, Inc. | 39,825 | $154.1K | 0.00% | +39,825 | New |
| Geode Capital Management, LLC | 55,148 | $213.5K | 0.00% | +4,421+8.7% | Added |
| Wells Fargo & Company | 64,981 | $251.5K | 0.00% | −350,000−84.3% | Reduced |
| Greenwich Wealth Management LLC | 76,341 | $295.0K | 0.02% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 120,651 | $466.9K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 213,814 | $827.5K | 0.00% | −2,000−0.9% | Reduced |
| Vanguard Group Inc | 244,082 | $944.6K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 362,198 | $1.40M | 0.00% | −44,413−10.9% | Reduced |
| Private Advisor Group, LLC | 744,513 | $2.88M | 0.02% | +714,500+2,380.6% | Added |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −141,435−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −37,018−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −25,760−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −19,475−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,745−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −10,803−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |